Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-05-053589
Filing Date
2005-11-08
Accepted
2005-11-08 17:14:13
Documents
4
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-18025_110qa.htm 10-Q/A 83575
2 MATERIAL CONTRACTS a05-18025_1ex10d14.htm EX-10.14 505745
3 302 CERTIFICATION a05-18025_1ex31d1.htm EX-31.1 27346
4 302 CERTIFICATION a05-18025_1ex31d2.htm EX-31.2 26902
  Complete submission text file 0001104659-05-053589.txt   644957
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-29889 | Film No.: 051187046
SIC: 2834 Pharmaceutical Preparations